Term
Equine protozoal myeloencephalitis (EPM) |
|
Definition
-Sarcocystis neurona (95%) -Neospora hughesi -dz incidence=1% -common dz in N and S America, Eastern states more cases, most common in regions with moderate temp -<5 yr old adults at higher risk |
|
|
Term
|
Definition
-performance in horses:TB and WB > risk than QH -increased incidence in fall and lowest incidence in winter -increased incidence if opposums seen -decreased risk in rodent-proof containerd -inc risk if previous EPM cases found on farm -incr incidence if horse previously stressed |
|
|
Term
|
Definition
-S. neurona, S. hughesi -Natural 2 host cycle -30-60% horses exposed and seroconvert -most horses d/n develop CNS signs -S. neurona: horses acquire the infection from opossum fecal contamination of pastures and horses feed -some horses-parasite invades the CNS -stress often precedes dz -focal, multifocal, or diffuse, asymmetric nonsuppurative inflammatory lesions in brain and particularly in spinal cord -focal discoloration -infected nerve cell bodies-> cell death, inflammation, edema |
|
|
Term
|
Definition
-dependant on area of CNS where ingestion occurs -80% of cases involve spinal cord only -Clinical signs are usually asymmetrical -cerebral signs include: depression, changes in mentation, and seizures -acute or insidious -rate of progression variable -highly variable -asymmetric ataxia, weakness, CP deficits, muscle atrophy -obscure lameness -behavioral changes (head tossing, difficulty maintaining a lead) -CN deficits, seizures, narcolepsy-like activity, urinary incontinence |
|
|
Term
|
Definition
-depression-RAS -Dysphagia-CN IX and X -Vestibular disorders-CN VII (head tilt, circling/leaning, vestibular ataxia) -Facial paralysis-CN VII (ear/eyelid droop/paresis, deviated muzzle) -Gait deficits-rubrospinal tracts, UMN signs, conscious proprioception deficits |
|
|
Term
|
Definition
-gait deficits-UMN and LMN signs: sensory ataxia/weakness, assymetric, may be vague-lameness, toe drag, circumduction, knuckling, short stride -muscle atrophy-LMN signs -bladder atony |
|
|
Term
|
Definition
-clinical signs: recognition of a multifocal asymmetric dz, use your clinical judgement -CSF tap: WBC, RBC, CK, protein, may be normal -three methods are used to detect antibodies to EPM in sera or in CSF samples: 1. western blot (less antigen specific, false positive, positive tests indicates exposure; CSF: serum abs, positive test d/n always indicate infx of the nervous tissue, healthy horses-20% will have a positive test result) 2. IFAT test 3, SAF2/3/4 ELISA |
|
|
Term
|
Definition
-immunofluorescent antibody test -provides a numerical titer for serum or CSF fluid -provides a likelihood that horse has EPM based on titer -Appears to be more accurate that Western blod -distinguishes: S. neurona and N. hughesi |
|
|
Term
EPM Dx: Antemortem tests (difficult) |
|
Definition
-Antemortem tests (S. neurona)-Western Blot, IFA, SAG2/3/4 ELISA |
|
|
Term
|
Definition
1. clinical signs-must have neuro diseases 2. Serum IFAT test: can have false negative results (10% of cases) so best to combine with CSF 3. CSF tap: cytology and IFAT 4. tx for EPM until test results returned |
|
|
Term
|
Definition
-Banamine -Ponazuril (Marquis) -Sulfadiazine and Pyrimethamine |
|
|
Term
|
Definition
-varies with how quicklydx -if is a delay of several weeks prognosis often poor -early dx and tx results in improvement of clinical signs in 75% horses -RELAPSES are common |
|
|
Term
Equine Herpesvirus-1 Myeloecncephalopathy |
|
Definition
-Epidemiology: sporadic, adult horses -EHV-1: respiratory dz, abortion -Neuro dz can precede or follow resp or abortive forms but d/n always |
|
|
Term
|
Definition
-herpesviridae: alpha herpes -EHV1 -EHV3 (urogenital dz) -EHV4 (resp virus)
-Gamma herpesvirus: -EHV2 -EHV5 |
|
|
Term
|
Definition
-respiratory -abortion (>50%)*3rd trimester>>>others -neonatal death -neurologic (10%)
-EHV1 endemic in equine population (prevalence varies with geographic location |
|
|
Term
Risk factors for neurologic form |
|
Definition
-latent state -stress -high fever on day 3 -pregnant mares -any age -season of year (fall, winter, spring) -transmission: inhalation, contact, ingestion |
|
|
Term
|
Definition
-adherence-nasopharyngeal epithelium, MALT -replication-resp. epithelium, lymphoid tissue -systemic circulation (viremia)-T lymphocytes, duration 21 d -endotheliotrophic-vasculitis, thrombosis, hemorrhages, ischemia, infarcts -viremia precedes (100%)-abortion; neuro dz (white matter> gray matter; brainstem) |
|
|
Term
|
Definition
-brain: multifocal lymphocytic vasculitis, hemorrhages, ischemia, necrosis -spinal cord: multifocal lymphocytic vasculitis, hemorrhages, axonal degeneration -other organs with vasculitis: lungs, kidneys |
|
|
Term
Severity of disease: EHV1 |
|
Definition
-Horses: age-older horses (neuro), health status, immune system -EHV1 genetic diversity |
|
|
Term
|
Definition
-Xanthochromic (yellow) -Nucleated cell count (1-19/ uL) -normal to mononuclear pleocytosis (lymphocytes0 -increased protein (>100-400 mg/dL) -majority >200 mg/dl |
|
|
Term
|
Definition
-CSF analysis -VI -Serology -Molecular (PCR)-qualitative, buffy coat, nasal/nasopharyngeal |
|
|
Term
|
Definition
-clinically affected horses -blood on EDTA and nasal swab -NO asymptomatic horses, except exposed horses |
|
|
Term
|
Definition
-supportive -prevent complications (i.e. decubital ulcers, neurologic-penile paralysis, pressure neuropathies, ischemic myelomalacia, cystitis, specific: antivirals, antiinflamm, antiox, neuroprotectants=Give acyclovir IV, give vacyclovir oral |
|
|
Term
|
Definition
-NO vax prevents against neural form of EHV-1 -ideal vax: -prevents -protects against infection -stimulates immune system -effective during viral intracellular cycle -no interference with maternal antibodies |
|
|
Term
**KNOW** During an outbreak there are three main goals |
|
Definition
1. early diagnosis (PCR) 2. prevent dissemination 3. therapeutic management
**Isolate infected horses!! |
|
|